| Literature DB >> 27471319 |
Emmie de Wit1, Shelby Kramer1, Joseph Prescott1, Kyle Rosenke1, Darryl Falzarano1, Andrea Marzi1, Robert J Fischer1, David Safronetz1, Thomas Hoenen1, Allison Groseth1, Neeltje van Doremalen1, Trenton Bushmaker1, Kristin L McNally1, Friederike Feldmann1, Brandi N Williamson1, Sonja M Best1, Hideki Ebihara1, Igor A C Damiani2, Brett Adamson2, Kathryn C Zoon3, Tolbert G Nyenswah4, Fatorma K Bolay5, Moses Massaquoi4, Armand Sprecher2, Heinz Feldmann1, Vincent J Munster1.
Abstract
The development of point-of-care clinical chemistry analyzers has enabled the implementation of these ancillary tests in field laboratories in resource-limited outbreak areas. The Eternal Love Winning Africa (ELWA) outbreak diagnostic laboratory, established in Monrovia, Liberia, to provide Ebola virus and Plasmodium spp. diagnostics during the Ebola epidemic, implemented clinical chemistry analyzers in December 2014. Clinical chemistry testing was performed for 68 patients in triage, including 12 patients infected with Ebola virus and 18 infected with Plasmodium spp. The main distinguishing feature in clinical chemistry of Ebola virus-infected patients was the elevation in alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, and γ-glutamyltransferase levels and the decrease in calcium. The implementation of clinical chemistry is probably most helpful when the medical supportive care implemented at the Ebola treatment unit allows for correction of biochemistry derangements and on-site clinical chemistry analyzers can be used to monitor electrolyte balance. Published by Oxford University Press for the Infectious Diseases Society of America 2016. This work is written by (a) US Government employee(s) and is in the public domain in the US.Entities:
Keywords: Ebola virus; West Africa; clinical chemistry
Mesh:
Substances:
Year: 2016 PMID: 27471319 PMCID: PMC5050461 DOI: 10.1093/infdis/jiw187
Source DB: PubMed Journal: J Infect Dis ISSN: 0022-1899 Impact factor: 5.226